ATE30326T1 - Cyclische pentapeptide mit somatostatin antagonistischer wirksamkeit und verfahren zur behandlung von saeugetieren damit. - Google Patents
Cyclische pentapeptide mit somatostatin antagonistischer wirksamkeit und verfahren zur behandlung von saeugetieren damit.Info
- Publication number
- ATE30326T1 ATE30326T1 AT84106363T AT84106363T ATE30326T1 AT E30326 T1 ATE30326 T1 AT E30326T1 AT 84106363 T AT84106363 T AT 84106363T AT 84106363 T AT84106363 T AT 84106363T AT E30326 T1 ATE30326 T1 AT E30326T1
- Authority
- AT
- Austria
- Prior art keywords
- mammals
- pentapeptids
- cyclic
- treatment
- methods
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 2
- 102000005157 Somatostatin Human genes 0.000 title abstract 2
- 108010056088 Somatostatin Proteins 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title abstract 2
- 229960000553 somatostatin Drugs 0.000 title abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 102000051325 Glucagon Human genes 0.000 abstract 1
- 108060003199 Glucagon Proteins 0.000 abstract 1
- 102000018997 Growth Hormone Human genes 0.000 abstract 1
- 108010051696 Growth Hormone Proteins 0.000 abstract 1
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 229960004666 glucagon Drugs 0.000 abstract 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/16—Somatostatin; related peptides
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/501,321 US4505897A (en) | 1983-04-18 | 1983-06-06 | Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith |
| EP84106363A EP0127899B1 (de) | 1983-06-06 | 1984-06-04 | Cyclische Pentapeptide mit Somatostatin antagonistischer Wirksamkeit und Verfahren zur Behandlung von Säugetieren damit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE30326T1 true ATE30326T1 (de) | 1987-11-15 |
Family
ID=23993046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT84106363T ATE30326T1 (de) | 1983-06-06 | 1984-06-04 | Cyclische pentapeptide mit somatostatin antagonistischer wirksamkeit und verfahren zur behandlung von saeugetieren damit. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4505897A (de) |
| EP (2) | EP0127899B1 (de) |
| JP (1) | JPS60501505A (de) |
| AT (1) | ATE30326T1 (de) |
| AU (1) | AU596784B2 (de) |
| CA (1) | CA1236451A (de) |
| DE (1) | DE3466879D1 (de) |
| IL (1) | IL72082A (de) |
| NZ (1) | NZ208376A (de) |
| WO (1) | WO1984004916A1 (de) |
| ZA (1) | ZA844222B (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4585755A (en) * | 1985-04-29 | 1986-04-29 | Merck & Co., Inc. | Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents |
| US4748153A (en) * | 1985-04-29 | 1988-05-31 | Merck & Co., Inc. | Compounds having somatostatin-like activity useful as local anti-inflammatory agents |
| US4612366A (en) * | 1985-06-17 | 1986-09-16 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| US4880778A (en) * | 1986-05-12 | 1989-11-14 | Eastman Kodak Company | Combinations having synergistic growth hormone releasing activity and methods for use thereof |
| DE3726517A1 (de) * | 1986-08-18 | 1988-03-03 | Sandoz Ag | Nasale zusammensetzungen, welche octreotid enthalten |
| US4839344A (en) * | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| US4880777A (en) * | 1987-09-01 | 1989-11-14 | Eastman Kodak Company | Synthetic peptides having growth hormone releasing activity |
| EP0400051B1 (de) * | 1988-01-28 | 1995-05-10 | Polygen Holding Corporation | Polypeptide mit hormonwachstumsbefreiender wirkung |
| US5662525A (en) * | 1989-11-20 | 1997-09-02 | Briggs; Rick A. | Participatory water play apparatus |
| CA2032559C (en) * | 1989-12-28 | 2001-11-06 | Kiyofumi Ishikawa | Endothelin antagonistic cyclic pentapeptides |
| US6183722B1 (en) | 1991-11-27 | 2001-02-06 | Diatide, Inc. | Somatostatin analogs |
| MY147327A (en) * | 1995-06-29 | 2012-11-30 | Novartis Ag | Somatostatin peptides |
| US5849293A (en) * | 1996-01-11 | 1998-12-15 | Cornell Research Foundation, Inc. | Use of human transferrin in controlling insulin levels |
| JPH09328499A (ja) * | 1996-02-20 | 1997-12-22 | American Cyanamid Co | 純粋なソマトスタチンアンタゴニストおよびその使用方法 |
| IT1283134B1 (it) * | 1996-07-08 | 1998-04-07 | Dox Al Italia Spa | Derivati sintetici e semisintetici di somatostatine utili nella stimolazione della crescita corporea, in particolare in |
| JPH10251296A (ja) * | 1997-03-06 | 1998-09-22 | American Cyanamid Co | ソマトスタチン拮抗薬として有用なペプチド |
| US6903074B1 (en) | 1999-06-04 | 2005-06-07 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Neuromedin b and somatostatin receptor agonists |
| IL146884A0 (en) * | 1999-06-04 | 2002-08-14 | Sod Conseils Rech Applic | Neuromedin b and somatostatin receptor agonists |
| GB0018891D0 (en) * | 2000-08-01 | 2000-09-20 | Novartis Ag | Organic compounds |
| US6786830B2 (en) * | 2002-06-28 | 2004-09-07 | Koala Corporation | Modular water play structure |
| WO2006063465A1 (en) * | 2004-12-15 | 2006-06-22 | Diamedica Inc. | Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists |
| CA2910544A1 (en) | 2014-10-30 | 2016-04-30 | Charles E. Decaro | Water amusement device |
| US10758831B2 (en) | 2014-11-17 | 2020-09-01 | Whitewater West Industries Ltd. | Interactive play center with interactive elements and consequence elements |
| US10576388B2 (en) | 2016-11-14 | 2020-03-03 | Whitewater West Industries Ltd. | Play center using structural monoliths for water delivery capabilities |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4101721A (en) * | 1976-12-09 | 1978-07-18 | Wisconsin Alumni Research Foundation | Solid phase synthesis of protected peptides |
| US4235886A (en) * | 1979-10-31 | 1980-11-25 | Merck & Co., Inc. | Cyclic hexapeptide somatostatin analogs |
| NZ195303A (en) * | 1979-10-31 | 1984-10-19 | Merck & Co Inc | Cyclic hexapeptide somatostatin analogues,and pharmaceutical compositions |
| US4427661A (en) * | 1982-07-30 | 1984-01-24 | Merck & Co., Inc. | Fluorinated cyclic hexapeptide somatostatin analogs |
| DE3303345A1 (de) * | 1983-02-02 | 1984-08-02 | Hoechst Ag, 6230 Frankfurt | Cyclische peptide mit somatostatin-wirkung |
-
1983
- 1983-06-06 US US06/501,321 patent/US4505897A/en not_active Expired - Lifetime
-
1984
- 1984-06-04 AT AT84106363T patent/ATE30326T1/de not_active IP Right Cessation
- 1984-06-04 DE DE8484106363T patent/DE3466879D1/de not_active Expired
- 1984-06-04 CA CA000455809A patent/CA1236451A/en not_active Expired
- 1984-06-04 EP EP84106363A patent/EP0127899B1/de not_active Expired
- 1984-06-05 EP EP84902476A patent/EP0145768A1/de not_active Withdrawn
- 1984-06-05 JP JP59502395A patent/JPS60501505A/ja active Pending
- 1984-06-05 ZA ZA844222A patent/ZA844222B/xx unknown
- 1984-06-05 NZ NZ208376A patent/NZ208376A/xx unknown
- 1984-06-05 AU AU30623/84A patent/AU596784B2/en not_active Expired
- 1984-06-05 WO PCT/US1984/000861 patent/WO1984004916A1/en unknown
- 1984-06-12 IL IL72082A patent/IL72082A/xx active IP Right Revival
Also Published As
| Publication number | Publication date |
|---|---|
| CA1236451A (en) | 1988-05-10 |
| EP0127899B1 (de) | 1987-10-21 |
| EP0127899A1 (de) | 1984-12-12 |
| WO1984004916A1 (en) | 1984-12-20 |
| EP0145768A1 (de) | 1985-06-26 |
| ZA844222B (en) | 1985-01-30 |
| NZ208376A (en) | 1988-07-28 |
| AU596784B2 (en) | 1990-05-17 |
| AU3062384A (en) | 1985-01-04 |
| IL72082A (en) | 1987-12-31 |
| JPS60501505A (ja) | 1985-09-12 |
| DE3466879D1 (en) | 1987-11-26 |
| US4505897A (en) | 1985-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE30326T1 (de) | Cyclische pentapeptide mit somatostatin antagonistischer wirksamkeit und verfahren zur behandlung von saeugetieren damit. | |
| DE69010893T2 (de) | Verfahren zur behandlung von koks sowie löschen desselben. | |
| DE3579129D1 (de) | Zusammensetzung und verfahren zur behandlung von kunststoffen mit alkalipermanganat-loesungen. | |
| DE68924132D1 (de) | Halbleiterbauteil und Verfahren zur dessen Herstellung. | |
| DE3789642D1 (de) | Apparat zur iontophoretischen behandlung mit medikamenten. | |
| DE3766534D1 (de) | Verfahren und system zum anreichern von wasser mit sauerstoff. | |
| DE3854111T2 (de) | Vorrichtung und verfahren zur behandlung mit plasma. | |
| ATE111701T1 (de) | Verfahren und vorrichtung zur herstellung von borstenwaren. | |
| DE68903482T2 (de) | Zement, verfahren zur herstellung dieses zements und verfahren zur herstellung von produkten mit diesem zement. | |
| DE3888205T2 (de) | Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür. | |
| DE3869542D1 (de) | Lumineszentes material, verfahren zur herstellung desselben und dasselbe verwendende elektrolumineszente vorrichtung. | |
| DE68905117D1 (de) | Verfahren zur stabilisierung von blutgewinnungsfaktoren. | |
| DE3777897D1 (de) | Verfahren zur herstellung von wasserstoff enthaltenden fluoraethylenen und chlorfluoraethylenen aus chlorfluoraethanen. | |
| DE3872614T3 (de) | Verfahren zur behandlung der unfruchtbarkeit und mittel zur verwendung dabei. | |
| DE3684922D1 (de) | Verfahren zur herstellung von 2-phenylbenzotriazolen und 2-phenylbenzotriazol-n-oxyden. | |
| DE237398T1 (de) | Verfahren zur herstellung biologisch aktiver polypeptide, so erhaltene polypeptide und diese enthaltende zusammensetzungen. | |
| DE68903208T2 (de) | Verfahren zur thermischen behandlung von laktoferrin. | |
| DE68911452D1 (de) | Cadmium-Anode vom Pastentyp und Verfahren zur Herstellung derselben. | |
| DE68922409T2 (de) | Verfahren zur gasartigen reinigung von halbleiterbauelementen. | |
| ATE167628T1 (de) | Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion | |
| DE3480654D1 (de) | Verfahren zur herstellung von zellularen gegenstaenden und verbundstoffen mit furanpraepolymeren. | |
| DE3679240D1 (de) | Verfahren zur behandlung von glas um ausbluehen zu verhindern und mit diesem verfahren behandeltes glas. | |
| DE3879570T2 (de) | Verfahren zur selektiven reduktion von polyhalosilanen mit alkylzinnhydriden. | |
| DE69812084D1 (de) | Verfahren zur behandlung von hyperprolaktinämia und prolaktinomen | |
| DE68907914D1 (de) | Verfahren zur behandlung von brandwunden. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |